Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
General Internal Medicine
•
Rheumatology
•
Hematology
•
Pediatric Hematology
•
Lupus nephritis
•
Antiphospholipid Syndrome
•
Nephrology
•
Glomerulonephritis
•
Anticoagulation
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
Related Questions
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
Can lupus anticoagulant be positive despite a normal aPTT?
Do you think the benefits of performing a repeat kidney biopsy to assess histologic evidence of disease activity or chronic damage outweigh the risks in a patient with recently treated lupus nephritis and improving creatinine levels?
What is your preferred treatment for refractory warm autoimmune hemolytic anemia with autoimmune neutropenia?
Do you check mycophenolate levels in patients prescribed mycophenolate who present with a lupus nephritis flare?
Do you recommend initiating immunosuppression and plasmapheresis in patients with dialysis dependent AKI in the setting of anti-GBM disease who do not have pulmonary involvement?
What steroid regimen do you typically use for induction therapy in patients with lupus nephritis?
What factors do you consider when advising a patient with lupus nephritis on the safety of becoming pregnant?
What do you feel are the potential barriers to widespread use of obinutuzumab in proliferative lupus nephritis?
How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?